Jørgen Ingerslev - Concepedia

Author

Jørgen Ingerslev

Aarhus University Hospital

Also Known As

Benny Sørensen, Jorgen Ingerslev, JØRGEN INGERSLEV, JØrgen Ingerslev, JøRgen Ingerslev, Jørgen Ingerslev

126

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Aarhus University Rigshospitalet University of Sheffield Institute of Haematology and Blood Transfusion

About

Jørgen Ingerslev is an author at Aarhus University Hospital specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	27	742
2	Health Sciences	10	10	1.1K
3	Public Health	2	2	57
4	Natural Sciences	1	1	14
5	Biochemistry	1	1	14

Jørgen Ingerslev

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Definitions in Hemophilia Frits R. Rosendaal, Louis M. Aledort, Jeanne M. Lusher, Thrombosis and Haemostasis ImmunohematologyLaboratory HematologyGranulocytePathogenesisHematology	2001	757
Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma U. Martinowitz, Gili Kenet, Eran Segal, The Journal of Trauma: Injury, Infection, and Critical Care	2001	448
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) Anne Goodeve, Jeroen Eikenboom, Giancarlo Castaman, Blood	2006	397
Clinical phenotypes and factor VII genotype in congenital factor VII deficiency Guglielmo Mariani, Falko H. Herrmann, Alberto Dolce, Thrombosis and Haemostasis	2005	253
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD Giancarlo Castaman, Stefan Lethagen, Augusto B. Federici, Blood	2008	202
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A Peter W. Collins, F. Baudo, Angela Huth‐Kühne, BMC Research Notes	2010	188
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis Benny Sørensen, Peter Johansen, G. Nielsen, Blood Coagulation & Fibrinolysis	2003	180
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) Sandra L. Haberichter, Giancarlo Castaman, Ulrich Budde, Blood	2008	168
Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders Christian Fenger‐Eriksen, Gary Moore, Savita Rangarajan, Transfusion	2010	129
Diagnostic Performance and Therapeutic Consequence of Thromboelastometry Activated by Kaolin versus a Panel of Specific Reagents Ole H. Larsen, Christian Fenger‐Eriksen, Kirsten Christiansen, Anesthesiology	2011	116

Page 1